Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Merck buys into PD-1/VEGF space as Summit comes for Keytruda
5 months ago
Deals
China
FDA approves PTC’s ultra-rare disease gene therapy for broader patient population than Europe
6 months ago
Cell/Gene Tx
FDA+
J&J takes 340B fight with federal government to court
6 months ago
Law
After stock slides, Amgen addresses bone density talk on obesity drug
6 months ago
R&D
New cancer class heats up as BioNTech buys out China partner and its PD-L1/VEGF drug
6 months ago
Deals
China
Pfizer looking to sell hospital drugs unit — reports
6 months ago
AstraZeneca CEO reaffirms commitment to China following executive's detention
6 months ago
China
Syndax's menin inhibitor succeeds in pivotal trial, but investors aren't impressed
6 months ago
R&D
Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug
6 months ago
R&D
Intercept is denied full FDA approval for Ocaliva, but claims it will keep drug on market
6 months ago
FDA+
Updated: AstraZeneca, Daiichi Sankyo replace lung cancer filing for Enhertu successor
6 months ago
R&D
Bayer not eyeing new deals to address Xarelto sales erosion
6 months ago
Novartis pays $150M upfront to Schrödinger in new drug deal, ramps up software use
6 months ago
Deals
R&D
GSK snags Parkinson's drug from Flagship startup Vesalius
6 months ago
Startups
Deals
23andMe to shut down its therapeutics division
6 months ago
Health Tech
Rapt cuts immunology program following clinical holds
6 months ago
FDA+
FDA lifts hold on Novavax vaccines after adverse event reclassified as ALS
6 months ago
R&D
Danish company pays $145M upfront to license nasal spray alternative to EpiPen
6 months ago
Deals
Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer
6 months ago
Cell/Gene Tx
FDA records request lands Chinese API manufacturer on blocked import list
6 months ago
FDA+
Manufacturing
GSK leaves biotech trade group BIO
6 months ago
Amgen and AstraZeneca share positive results in chronic rhinosinusitis
6 months ago
R&D
Eisai slashes Leqembi sales forecast by almost $100M
6 months ago
Pfizer to invest $1B in China over next five years — reports
6 months ago
Financing
China
First page
Previous page
23
24
25
26
27
28
29
Next page
Last page